Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01733884cc888894a4579e6d14f90508 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86f30c3aab083283ae5d88d5a2d8c1b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67fa506b0dcb71f508b68d05afc6d606 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 |
filingDate |
2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a6afbfa1c6fe702cebe01e7af386785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2ac7bd7e28d4b54b399e47c20b129c |
publicationDate |
2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006135692-A2 |
titleOfInvention |
Processes for the preparation of docetaxel |
abstract |
The present invention provides processes for the production of docetaxel. Docetaxel is produced by protecting the C(7) and the C(10) hydroxy groups of 10-DAB with a bridging silicon-based protecting group. The resulting 7,10 protected 10-DAB derivative is then derivatized and deprotected to form docetaxel. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010138010-A2 |
priorityDate |
2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |